Meyers Michael L.
Insider CIK 1664204 · SNDX SVP, Chief Medical Officer · NUVL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 8,361 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 40,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 15,000 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 3,789 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer deriv | 2026-07-15 | 2026-07-15 | 4,147 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | D To issuer | 2026-07-15 | 2026-07-15 | 3,444 | — | $0 | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | U Tender | 2026-07-15 | 2026-07-15 | 5,146 | $124.00 | $638.1K | 0 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2026-06-16 | 2026-06-18 | 3,444 | — | $0 | 8,590 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 4,147 | — | $0 | 4,147 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2025-06-18 | 2025-06-20 | 2,647 | — | $0 | 5,146 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 3,789 | — | $0 | 3,789 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award | 2024-06-12 | 2024-06-14 | 2,499 | — | $0 | 2,499 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NUVL Nuvalent, Inc. | A Award deriv | 2022-10-04 | 2022-10-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2022-02-02 | 2022-02-03 | 17,350 | $15.79 | $274.0K | 17,350 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | J Other | 2022-01-31 | 2022-02-03 | 1,714 | $12.39 | $21.2K | 23,280 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise deriv | 2021-12-30 | 2022-01-03 | 5,900 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | M Exercise | 2021-12-30 | 2022-01-03 | 5,900 | $8.77 | $51.7K | 21,566 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | P Buy | 2021-04-26 | 2021-04-28 | 500 | $15.46 | $7.7K | 15,666 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2021-02-03 | 2021-02-05 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | J Other | 2021-01-31 | 2021-02-05 | 1,771 | $12.00 | $21.3K | 15,166 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | J Other | 2020-07-31 | 2021-02-05 | 2,665 | $7.97 | $21.2K | 13,395 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award | 2020-07-06 | 2020-07-08 | 3,500 | — | $0 | 10,730 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2020-02-12 | 2020-02-14 | 50,825 | — | $0 | 50,825 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | P Buy | 2019-03-21 | 2019-03-22 | 104 | $4.87 | $506 | 7,222 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | P Buy | 2019-03-21 | 2019-03-22 | 1,000 | $4.93 | $4.9K | 7,118 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | P Buy | 2019-03-21 | 2019-03-25 | 8 | $4.87 | $39 | 7,230 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2019-02-06 | 2019-02-08 | 104,325 | — | $0 | 104,325 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | J Other | 2019-01-31 | 2019-02-08 | 3,720 | $4.76 | $17.7K | 6,118 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | P Buy | 2018-10-30 | 2018-11-07 | 200 | $4.79 | $958 | 2,398 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2018-03-01 | 2018-03-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2017-02-06 | 2017-02-08 | 66,100 | — | $0 | 66,100 | SEC↗ |